Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes
Authors:
- Fabrice SchneiderFSFabrice Schneider
- Pierre-Jean SaulnierPSPierre-Jean Saulnier
- Elise GandEGElise Gand
- Mathieu DesvergnesMDMathieu Desvergnes
- Nicolas LefortNLNicolas Lefort
- Eric ThorinETEric Thorin
- Nathalie Thorin-TrescasesNTNathalie Thorin-Trescases
- Kamel MohammediKMKamel Mohammedi
- Stéphanie RagotSRStéphanie Ragot
- Jean-Baptiste RiccoJRJean-Baptiste Ricco
- Samy HadjadjSHSamy Hadjadj
Open Access
- 8 June 2018
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 17 (1) , 1-12
Abstract
Patients with type 2 diabetes (T2D) face a high amputation rate. We investigated the relationship between the level of amputation and the presence of micro or macro-vascular disease and related circulating biomarkers, Tumor Necrosis Factor Receptor 1 (TNFR1) and Angiopoietin like-2 protein (ANGPTL2). We have analyzed data from 1468 T2D participants in a single center prospective cohort (the SURDIAGENE cohort). Our outcome was the occurrence of lower limb amputation categorized in minor (below-ankle) or major (above ankle) amputation. Microvascular disease was defined as a history of albuminuria [microalbuminuria: uACR (urinary albumine-to-creatinine ratio) 30–299 mg/g or macroalbuminuria: uACR ≥ 300 mg/g] and/or severe diabetic retinopathy or macular edema. Macrovascular disease at baseline was divided into peripheral arterial disease (PAD): peripheral artery revascularization and/or major amputation and in non-peripheral macrovascular disease: coronary artery revascularization, myocardial infarction, carotid artery revascularization, stroke. We used a proportional hazard model considering survival without minor or major amputation. During a median follow-up period of 7 (0.5) years, 79 patients (5.5%) underwent amputation including 29 minor and 50 major amputations. History of PAD (HR 4.37 95% CI [2.11–9.07]; p < 0.001), severe diabetic retinopathy (2.69 [1.31–5.57]; p = 0.0073), male gender (10.12 [2.41–42.56]; p = 0.0016) and serum ANGPTL2 concentrations (1.25 [1.08–1.45]; p = 0.0025) were associated with minor amputation outcome. History of PAD (6.91 [3.75–12.72]; p < 0.0001), systolic blood pressure (1.02 [1.00–1.03]; p = 0.004), male gender (3.81 [1.67–8.71]; p = 0.002), and serum TNFR1 concentrations (HR 13.68 [5.57–33.59]; p < 0.0001) were associated with major amputation outcome. Urinary albumin excretion was not significantly associated with the risk of minor and major amputation. This study suggests that the risk factors associated with the minor vs. major amputation including biomarkers such as TNFR1 should be considered differently in patients with T2D.Keywords
Funding Information
- Ministère de la Santé
- Association Francaise des Diabetiques
- groupement pour l'étude des maladies métaboliques et systémiques
- Montreal Heart Institute (133649, 14496)
This publication has 40 references indexed in Scilit:
- Angiopoietin-Like Protein 2 Is Associated With Chronic Kidney Disease in a General Japanese PopulationCirculation Journal, 2013
- The effect of risk and race on lower extremity amputations among Medicare diabetic patientsJournal of Vascular Surgery, 2012
- Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trialAmerican Heart Journal, 2012
- Inflammation in the pathogenesis of microvascular complications in diabetesFrontiers in Endocrinology, 2012
- Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 DiabetesDiabetes Care, 2011
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011
- Angiopoietin-like Protein 2 Promotes Chronic Adipose Tissue Inflammation and Obesity-Related Systemic Insulin ResistanceCell Metabolism, 2009
- Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic SubjectsDiabetes Care, 2008
- Prevalence of and Risk Factors for Peripheral Arterial Disease in the United StatesCirculation, 2004
- Risk Factors Predicting Lower Extremity Amputations in Patients With NIDDMDiabetes Care, 1996